Dr. Anil Bajnath, MD is a board-certified physician, medical professor, published author, and a sought after expert on the science of growing older. He's the founder of The Institute for Human Optimization, where he and his team combine genetic testing, nutrition, and functional medicine to help patients heal the biological imbalances that cause disease.


  1. Algren, D. A. (2008). Review of n-acetylcysteine for the treatment of acetaminophen (paracetamol) toxicity in pediatrics. Second Meeting of the Subcommittee of the Expert Committee on the Selection and Use of Essential Medicines, 1–18. https://www.who.int/selection_medicines/committees/subcommittee/2/acetylcysteine_rev.pdf
  2. Dludla, P. V., Nkambule, B. B., Mazibuko-Mbeje, S. E., Nyambuya, T. M., Marcheggiani, F., Cirilli, I., Ziqubu, K., Shabalala, S. C., Johnson, R., Louw, J., Damiani, E., & Tiano, L. (2020). N-acetyl cysteine targets hepatic lipid accumulation to curb oxidative stress and inflammation in nafld: A comprehensive analysis of the literature. Antioxidants, 9(12), 1–20. https://doi.org/10.3390/antiox9121283
  3. Post-White, J., Ladas, E. J., & Kelly, K. M. (2007). Advances in the use of milk thistle (Silybum marianum). Integrative Cancer Therapies, 6(2), 104–109. https://doi.org/10.1177/1534735407301632
  4. Valenzuela, A., Aspillaga, M., Vial, S., & Guerra, R. (1989). Selectivity of silymarin on the increase of the glutathione content in different tissues of the rat. Planta Medica, 55(5), 420–422. https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-2006-962056
  5. Desplaces, A., Choppin, J., Vogel, G., & Trost, W. (1975). The effects of silymarin on experimental phalloidine poisoning. Arzneimittelforschung, 25(1), 89–96. https://pubmed.ncbi.nlm.nih.gov/125090/
  6. Thuluvath, P. J., & Triger, D. R. (1992). Selenium in chronic liver disease. Journal of Hepatology, 14(2–3), 176–182. https://doi.org/10.1016/0168-8278(92)90155-I
  7. Fayez, A. M., Zakaria, S., & Moustafa, D. (2018). Alpha lipoic acid exerts antioxidant effect via Nrf2/HO-1 pathway activation and suppresses hepatic stellate cells activation induced by methotrexate in rats. Biomedicine & Pharmacotherapy, 105, 428–433. https://doi.org/10.1016/J.BIOPHA.2018.05.145
  8. Vera-Ramirez, L., Pérez-Lopez, P., Varela-Lopez, A., Ramirez-Tortosa, M., Battino, M., & Quiles, J. L. (2013). Curcumin and liver disease. BioFactors, 39(1), 88–100. https://doi.org/10.1002/biof.1057

This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.